V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270010814 | 270013065 | null | 79.4 | Neo-adjuvant (N) | 2017-11-27 | 2017-11-27 | CARBOPLATIN + RT | N | N | 270021264 | CETUXIMAB + MDG |
| 270010815 | 270013065 | 1.55 | 80.9 | Adjuvant (A) | 2017-08-09 | 2017-08-09 | Carboplatin AUC 2 - 5 | N | N | 270021264 | CETUXIMAB + RT |
| 270010816 | 270006372 | null | 31.7 | Neo-adjuvant (N) | 2017-10-31 | 2017-11-02 | CARBOPLATIN + RT | N | N | 270021448 | CARBOPLATIN + PACLITAXEL + RT |
| 270010817 | 270006373 | null | 75.6 | Adjuvant (A) | 2014-12-15 | 2014-12-17 | Carboplatin AUC 2 - 5 | null | N | 270021523 | CETUXIMAB + RT |
| 270010818 | 270006374 | null | 67 | null | 2013-12-01 | 2013-12-22 | CVP R | N | N | 270021551 | CARBOPLATIN + PEMETREXED |
| 270010819 | 270006375 | 1.62 | 57.2 | Palliative (P) | 2019-04-27 | 2019-04-27 | CETUXIMAB + RT | N | N | 270021726 | CETUXIMAB + RT |
| 270010820 | 270006375 | null | null | Palliative (P) | 2017-03-09 | 2017-04-03 | Carboplatin + Etoposide IV 3 day | N | Y | 270021726 | ENZALUTAMIDE |
| 270010821 | 270016145 | 1.75 | 72 | Palliative (P) | 2018-01-14 | 2018-01-15 | Folfirinox | 02 | N | 270021755 | CARBOPLATIN + VINORELBINE |
| 270010822 | 270016145 | 1.57 | 54 | Palliative (P) | 2017-02-15 | 2017-02-15 | Cetuximab + Radiotherapy Load | N | N | 270021755 | CETUXIMAB |
| 270010823 | 270016145 | 1.61 | 90.3 | Curative (C) | 2013-12-16 | 2013-12-30 | null | N | N | 270021755 | NOT MATCHED |
| 270010824 | 270006376 | 1.67 | 73.4 | Adjuvant (A) | 2018-03-09 | 2018-03-09 | Bevacizumab 7.5mg/kg | Y | N | 270021861 | SCOT TRIAL |
| 270010825 | 270006377 | null | 78.75 | Palliative (P) | 2017-03-09 | 2017-03-28 | CETUXIMAB + RT | N | null | 270021908 | CARBOPLATIN + RT |
| 270010826 | 270006378 | 1.59 | 65 | Neo-adjuvant (N) | 2014-12-26 | 2015-01-03 | FLUOROURACIL + MITOMYCIN | 02 | null | 270021916 | CETUXIMAB + RT |
| 270010827 | 270006379 | 1.66 | 95.5 | Adjuvant (A) | 2017-06-01 | 2017-06-03 | CETUXIMAB + RT | Y | N | 270021935 | GEMCARBO |
| 270010828 | 270006380 | 1.75 | 72.6 | Curative (C) | 2014-09-21 | 2014-09-22 | Carboplatin AUC 6 - 10 | N | N | 270021950 | CETUXIMAB + IRINOTECAN + MDG |
| 270010829 | 270006381 | 1.64 | 73.6 | Adjuvant (A) | 2017-06-10 | 2017-06-13 | CARBOPLATIN + RT | 02 | N | 270021968 | ECX |
| 270010830 | 270006382 | 1.75 | 67.6 | Curative (C) | 2013-03-20 | 2013-03-27 | Capecitabine (14 days)+Carboplatin | N | N | 270021973 | PAZOPANIB |
| 270010831 | 270013067 | null | null | Not known (9) | 2014-07-10 | 2014-07-24 | CVP R | N | N | 270022011 | FLUOROURACIL + RT |
| 270010832 | 270006383 | 1.65 | 67.8 | Neo-adjuvant (N) | 2015-03-27 | 2015-03-29 | Cetuximab + Radiotherapy Load | 2 | N | 270022055 | CAP + RT |
| 270010833 | 270006384 | 1.78 | 104 | null | null | 2015-11-10 | Capecitabine (21days) + Carboplatin | 01 | N | 270022082 | BEVACIZUMAB |
| 270010834 | 270006385 | null | 115 | Neo-adjuvant (N) | 2013-09-11 | 2013-10-28 | CAP + RT | N | N | 270022128 | CARBOPLATIN + PACLITAXEL + RT |
| 270010835 | 270006386 | 1.78 | null | Adjuvant (A) | 2018-08-14 | 2018-08-15 | FLUOROURACIL + RT | N | null | 270022198 | OXALIPLATIN |
| 270010836 | 270006387 | null | 91.35 | null | 2017-08-24 | 2017-09-20 | Carboplatin AUC 6 - 10 | N | Y | 270022200 | FEC + DOCETAXEL |
| 270010837 | 270006388 | 1.7 | 28.1 | Curative (C) | 2015-12-27 | 2015-12-29 | CETUXIMAB | N | N | 270022303 | CETUXIMAB + RT |
| 270010838 | 270013068 | 1.5 | 62.4 | Adjuvant (A) | 2015-01-02 | 2015-01-04 | Cetuximab + Radiotherapy Load | 2 | N | 270022394 | CAPECITABINE + MITOMYCIN + RT |
| 270010839 | 270006389 | null | 118.7 | Palliative (P) | 2017-09-19 | 2017-10-01 | BENDAMUSTINE + RITUXIMAB | null | N | 270022469 | DOCETAXEL |
| 270010840 | 270006390 | 1.71 | 84 | Disease modification (D) | 2015-06-17 | 2015-07-17 | GEMCARBO | N | N | 270022491 | CISPLATIN + FLUOROURACIL + RT |
| 270010841 | 270006390 | 0 | 69 | Curative (C) | 2015-11-14 | 2015-11-15 | Cetuximab + Radiotherapy Load | N | N | 270022491 | CETUXIMAB |
| 270010842 | 270016146 | null | null | Curative (C) | 2017-12-01 | 2018-01-02 | Chlorambucil | null | Y | 270022580 | CARBOPLATIN |
| 270010843 | 270017912 | 1.85 | null | Palliative (P) | 2016-01-06 | 2016-01-06 | null | N | N | 270022687 | ENZALUTAMIDE |
| 270010844 | 270006391 | 1.72 | 77 | Palliative (P) | 2016-12-07 | 2016-12-21 | FOXTROT TRIAL | N | N | 270022690 | CAP + RT |
| 270010845 | 270013070 | 1.66 | 75.3 | Curative (C) | 2017-06-20 | 2017-06-20 | IBRUTINIB | N | N | 270022795 | IMATINIB |
| 270010846 | 270013070 | 1.83 | 75.3 | Not known (9) | 2015-03-31 | 2015-04-25 | GDP | 02 | N | 270022795 | GDP |
| 270010847 | 270013070 | 1.76 | 65.3 | Adjuvant (A) | 2017-04-23 | 2017-04-25 | Capecitabine (14 day) + Irinotecan | 02 | N | 270022795 | CISPLATIN + FLUOROURACIL + RT |
| 270010848 | 270013070 | 1.6 | 57.1 | Curative (C) | 2014-06-20 | 2014-07-02 | Cisplatin + Vinorelbine (PO) | N | N | 270022795 | CETUXIMAB + OXALIPLATIN + MDG |
| 270010849 | 270013070 | null | null | Curative (C) | 2014-05-28 | 2014-06-02 | CISPLATIN + GEMCITABINE | null | null | 270022795 | CETUXIMAB + RT |
| 270010850 | 270006392 | 1.84 | 57.75 | Curative (C) | 2015-07-17 | 2015-07-17 | Cetuximab + Radiotherapy Load | N | N | 270023047 | CARBOPLATIN |
| 270010851 | 270006392 | null | 83.05 | Palliative (P) | 2017-02-07 | 2017-02-09 | CETUXIMAB + RT | N | N | 270023047 | PEMBROLIZUMAB |
| 270010852 | 270006392 | 1.54 | 47 | Curative (C) | 2018-05-10 | 2018-05-10 | Carbo F | 02 | N | 270023047 | CETUXIMAB |
| 270010853 | 270006392 | null | 97 | null | 2017-06-04 | 2017-06-04 | Bevacizumab + Irinotecan + MdG | 02 | Y | 270023047 | GEMCARBO |
| 270010854 | 270006393 | 1.63 | 59.6 | null | 2018-01-29 | 2018-01-29 | CAPECITABINE + CETUXIMAB + CISPLATIN | 02 | Y | 270023386 | CETUXIMAB |
| 270010855 | 270006394 | null | 93 | Curative (C) | null | 2017-06-10 | FLUOROURACIL + MITOMYCIN + RT | N | N | 270023442 | GEMCARBO |
| 270010856 | 270006395 | 1.65 | 79.8 | Palliative (P) | 2016-08-23 | 2016-08-24 | FLAG | N | Y | 270023466 | CHOP |
| 270010857 | 270006396 | 1.52 | 68 | Adjuvant (A) | 2018-01-20 | 2018-01-20 | Carboplatin AUC 2 - 5 | 02 | null | 270023485 | CETUXIMAB |
| 270010858 | 270006397 | null | 61 | Curative (C) | 2017-07-10 | 2017-07-10 | CARBOPLATIN + RT | N | Y | 270023548 | CETUXIMAB + RT |
| 270010859 | 270006398 | 1.8 | 77.35 | Palliative (P) | 2017-01-14 | 2017-02-05 | CARBOPLATIN + RT | N | N | 270023669 | CETUXIMAB + RT |
| 270010860 | 270006399 | 0 | 84 | Curative (C) | 2017-11-13 | 2017-11-13 | Carboplatin + Etoposide IV 3 day | N | N | 270023749 | IPILIMUMAB |
| 270010861 | 270013072 | 1.63 | 58.5 | Palliative (P) | 2015-03-14 | 2015-03-20 | Mitomycin Intravesical | N | N | 270023765 | CARBOPLATIN + ETOPOSIDE |
| 270010862 | 270006400 | 1.75 | 65.2 | Palliative (P) | 2014-11-01 | 2014-11-09 | Bevacizumab 7.5mg/kg | Y | N | 270023787 | CETUXIMAB + RT |
| 270010863 | 270013073 | null | 77.35 | Adjuvant (A) | 2017-09-20 | 2017-10-11 | Cisplatin + Fluorouracil + RT 5day | N | N | 270023795 | GEMCITABINE |